Edition:
United States

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

1.72USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
44,191
52-wk High
$2.29
52-wk Low
$0.78

Latest Key Developments (Source: Significant Developments)

Aptose Biosciences Files For Offering Of Up To 6 Mln Of Its Common Shares By The Selling Shareholder
Tuesday, 28 Nov 2017 04:29pm EST 

Nov 28 (Reuters) - Aptose Biosciences Inc ::APTOSE BIOSCIENCES INC FILES FOR OFFERING OF UP TO 6.0 MILLION OF CO'S COMMON SHARES BY THE SELLING SHAREHOLDER - SEC FILING‍​.  Full Article

Aptose Biosciences Inc Q3 loss per share C$0.14
Tuesday, 14 Nov 2017 04:00pm EST 

Nov 14 (Reuters) - Aptose Biosciences Inc :Aptose reports results for the third quarter ended September 30, 2017.Q3 loss per share C$0.14.Aptose Biosciences Inc - ‍total cash and cash equivalents and investments as of September 30, 2017 were $13.6 million​.  Full Article

Aptose Biosciences Inc qtrly earnings per share $0.15
Tuesday, 8 Aug 2017 04:05pm EDT 

Aug 8 (Reuters) - Aptose Biosciences Inc :Aptose reports results for the second quarter ended June 30, 2017.Aptose Biosciences Inc qtrly earnings per share $0.15.  Full Article

Aptose Q1 loss per share C$0.25
Thursday, 11 May 2017 04:02pm EDT 

May 11 (Reuters) - Aptose Biosciences Inc ::Aptose reports results for the first quarter ended March 31, 2017.Q1 loss per share C$0.25.  Full Article

Aptose reports Q4 and year end 2016 results
Tuesday, 28 Mar 2017 05:03pm EDT 

Aptose Biosciences Inc - : Aptose reports fourth quarter and year end 2016 results .Q4 loss per share c$0.26.  Full Article

Aptose Biosciences Q2 loss per share C$0.46
Tuesday, 9 Aug 2016 04:15pm EDT 

Aptose Biosciences Inc : Aptose biosciences reports financial results for the second quarter ended june 30, 2016 .Q2 loss per share c$0.46.  Full Article

Aptose Biosciences, CrystalGenomics sign cancer drug deal
Wednesday, 8 Jun 2016 08:00am EDT 

Aptose Biosciences Inc :Co and crystalgenomics says exclusive global option and license agreement focused on development of cg026806 (cg'806).  Full Article

Aptose Biosciences Q1 loss per share C$0.42
Tuesday, 10 May 2016 04:15pm EDT 

Aptose Biosciences Inc : Q1 loss per share C$0.42 . Q1 earnings per share view C$-0.37 -- Thomson Reuters I/B/E/S .Aptose Bioscience reports results for the first quarter ended March 31, 2016.  Full Article

BRIEF-Aptose Biosciences Inc Q3 loss per share C$0.14

* Aptose reports results for the third quarter ended September 30, 2017